Chicago looks to end ebola virus monitoring | Crain's Chicago Business
Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.
Stay updated with breaking news from William Brinkerhoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.
/PRNewswire/ -- EVOQ Therapeutics, Inc. (EVOQ), a biopharmaceutical company focused on the discovery and development of drugs to treat patients afflicted with...
A week after signing a lucrative licensing agreement, the top management at Ann Arbor-based pharmaceutical startup Evoq Therapeutics Inc. gets replaced. The company announced last week that public biopharmaceutical conglomerate Gilead Sciences Inc. would license its rheumatoid arthritis and lupus…
Giljohann departed the CEO role at Exicure with other top executives amid sustained money loss in 2021 but remained with the company as a board member until February 2022.
Gilead Sciences, Inc. (Nasdaq: GILD) and EVOQ Therapeutics, Inc. (EVOQ) today announced a collaboration and licensing agreement to advance EVOQ’s proprietary technology for the treatment of rheumatoid arthritis (RA) and lupus. EVOQ’s NanoDisc technology is designed to enable lymph-targeted delivery of ...